RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors?

Strand, V

Strand, V (corresponding author), Stanford Univ, Div Immunol Rheumatol, Palo Alto, CA 94304 USA.

RMD OPEN, 2021; 7 (1):